Carbetapentane Side Effects
Applies to carbetapentane: oral suspension extended release.
Warning
Do not use carbetapentane if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.
Get emergency medical help if you have any of these signs of an allergic reaction while taking carbetapentane: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using carbetapentane and call your doctor at once if you have:
-
confusion, hallucinations;
-
severe drowsiness; or
-
seizure (convulsions).
Common side effects may include:
-
dizziness, drowsiness, tired feeling;
-
problems with balance or coordination;
-
anxiety; or
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to carbetapentane: oral suspension extended release.
Gastrointestinal
Gastrointestinal side effects have included nausea and other gastrointestinal disturbances.[Ref]
Nervous system
Nervous system side effects have included dizziness and drowsiness. Other potential reactions include anxiety, disturbed coordination, euphoria, fatigue, headache, acute labyrinthitis, neuritis, paresthesias, tinnitus, and vertigo.[Ref]
Hypersensitivity
Hypersensitivity side effects have included pruritus, rash, and urticaria. Anaphylactic shock has been reported.[Ref]
Dermatologic
Dermatologic side effects have included photosensitivity. Rare cases of allergic exanthema have been associated with carbetapentane use.[Ref]
Hematologic
Hematologic side effects have included rare cases of leukopenia reported in patients receiving carbetapentane.[Ref]
More about carbetapentane
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: antitussives
Related treatment guides
References
1. Product Information. solotuss (carbetapentane). Hawthorn Pharmaceuticals. 2007.
2. Multum Information Services, Inc. Expert Review Panel
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.